Insider Shareholders with Direct Ownership of Roivant Sciences Ltd. (ROIV)
This section provides a comprehensive overview of the insiders with direct ownership of Roivant Sciences Ltd. (ROIV). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Roivant Sciences Ltd. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Dexcel Pharma Technologies Ltd.
> 10% Shareholder |
4,040,285 | 0 | 102,849,443 $1.23 Billion | 3 |
Nov 10, 2022
Added 3.74%
|
|
Vivek Ramaswamy
> 10% Shareholder |
1,029,735 | 7,509,520 | 51,929,426 $622 Million | 12 |
Jan 02, 2024
Reduced 5.46%
|
|
Mayukh Sukhatme
Pres&Chief Investment Officer |
20,242,602 | 4,430,780 | 18,836,547 $225 Million | 11 |
Dec 18, 2024
Reduced 2.14%
|
|
Matthew Gline
CEO |
19,290,133 | 3,621,632 | 17,350,114 $208 Million | 51 |
Nov 20, 2024
Reduced 0.06%
|
| 86,373 | 3,309,862 | 7,289,093 $87.3 Million | 7 |
Sep 12, 2024
Reduced 0.04%
|
|
| 86,373 | 503,000 | 1,277,178 $15.3 Million | 5 |
Sep 25, 2024
Reduced 9.56%
|
|
|
Eric Venker
President & COO |
4,400,950 | 5,183,418 | 606,525 $7.26 Million | 105 |
Nov 20, 2024
Reduced 14.15%
|
|
Richard Pulik
CFO |
105,395 | 59,751 | 276,601 $3.31 Million | 27 |
Nov 28, 2024
Reduced 0.84%
|
|
Rakhi Kumar
Chief Accounting Officer |
775,035 | 832,858 | 207,408 $2.48 Million | 68 |
Nov 20, 2024
Reduced 0.46%
|
| 110,315 | 12,459 | 97,856 $1.17 Million | 17 |
Oct 21, 2024
Added 2.3%
|
|
| 104,460 | 10,788 | 93,665 $1.12 Million | 17 |
Oct 21, 2024
Added 1.3%
|
|
| 52,142 | 0 | 52,142 $624,139 | 1 |
Sep 15, 2022
Added 50.0%
|
|
| 42,405 | 4,368 | 38,037 $455,302 | 10 |
Oct 21, 2024
Added 4.07%
|
|
| 30,353 | 977 | 29,376 $351,630 | 8 |
Sep 12, 2024
Reduced 2.95%
|